CLINICAL_TRIALS
trial_result
· 2008-09-11
Clinical Trial Update: Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial [Phase 4]
Summary
A Phase 4 clinical trial evaluating rheopheresis for dry age-related macular degeneration has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Apheresis Research Institute | Conditions: Dry Age Related Macular Degeneration | Phase 4 | Status: COMPLETED